share_log

格隆汇公告精选(港股)︱理想汽车-W(02015.HK)2023年度首次扭亏为盈并实现健康盈利 现金储备已增至1036.7亿元

Gelonghui Announcement Selection (Hong Kong Stock) | Ideal Automobile-W (02015.HK) turned a loss into profit for the first time in 2023 and achieved a healthy profit. Cash reserves have increased to 103.67 billion yuan

Gelonghui Finance ·  Feb 26 09:47

[Today's focus]

Ideal Automobile-W (02015.HK) turned a loss into profit for the first time in 2023 and achieved a healthy profit. Cash reserves have increased to 103.67 billion yuan

Ideal Automobile-W (02015.HK) announced unaudited financial results for the quarter and full year ended December 31, 2023.

In the fourth quarter of 2023, vehicle sales revenue was RMB 40.38 billion, up 133.8% year on year and 20.1% month on month; total revenue was RMB 41.73 billion, up 136.4% year on year and 20.3% month on month; gross profit was RMB 9.79 billion, up 174.4% year on year and 28.0% month on month. Net profit was RMB5.75 billion, up 20068.2% year on year, up 104.5% month on month; non-US GAAP net profit was RMB4.59 billion, up 374.2% year on year, up 32.3% month on month.

For the full year of 2023, vehicle sales revenue in 2023 was RMB 122.09 billion, up 172.7% year on year; total revenue was RMB 123.85 billion, up 173.5% year on year; gross profit was RMB 27.50 billion, up 212.8% year on year. Gross margin was 22.2% in 2023, compared to 19.4% in 2022. Net profit was RMB11.81 billion, while net loss for 2022 was RMB2.03 billion. The net diluted earnings per American Depositary Share attributable to common shareholders was RMB 11.10. Net cash from operating activities in 2023 was RMB 50.69 billion, an increase of 586.9% over RMB 7.38 billion in 2022. Free cash flow in 2023 was RMB 44.19 billion, up 1,861.8% from RMB 2.25 billion in 2022.

Mr. Li Xiang, Chairman and CEO of Ideal Auto, commented: “In 2023, when competition is fierce in the NEV market, Ideal Auto achieved excellent results with the three models in the Ideal L series. The annual delivery volume increased by 182.2% year-on-year to 376,030 units, making it the sales leader for NEVs over 300,000 yuan in the Chinese market. In December, we launched OTA5.0 vehicle software to Ideal L series users. Through intelligent driving and comprehensive improvements in intelligent space functions, we brought a better car experience to home users. Significant growth in scale, continuous deepening of R&D, and continuous improvement in operating efficiency drove us to achieve the best financial performance in history in 2023, and also laid a solid foundation for the ideal car to enter 2024, when the product matrix is richer and market demand is more diverse.”

Mr. Li Tie, Chief Financial Officer of Ideal Auto, added, “Ideal Auto once again achieved strong results in the fourth quarter, and many financial indicators hit record highs. Record vehicle deliveries drove fourth-quarter revenue up 136.4% yoy to RMB41.73 billion, and full-year revenue up 173.5% yoy to RMB123.85 billion. With the growth of business scale and optimization of production, supply and marketing collaboration, gross margin reached 23.5% in the fourth quarter and 22.2% for the whole year. Furthermore, 2023 was also the first year the company turned a loss into profit and achieved a healthy profit, with a net profit of RMB 11.81 billion for the whole year. By the end of 2023, our cash reserves had increased to RMB 103.67 billion. In 2024, healthy profitability and financial strength will support Ideal Auto to deepen R&D, expand its business scale, and continue to lead the rapid transformation of China's NEV market.”

[Important matters]

NIO - SW (09866.HK) signs technology licensing agreement with Forseven Limited

Zhongji Longevity Science (00767.HK) plans to establish a joint venture mainly to trade biomedical products

Pudat Technology (00650.HK): Issued Incellplate Cu series chain copper plating equipment to customers

Guohong Hydrogen Energy (09663.HK) proposes to implement full circulation of H shares

Lok Wah Entertainment (02306.HK) and Yuanlong Yatu (002878.SZ) signed a strategic cooperation agreement

[Financial results]

BeiGene (06160.HK)'s total revenue in 2023 increased 74% to $2.5 billion, looking forward to a transformative breakthrough in the new year

Comprehensive profit attributable to shareholders of Guohao Group (00053.HK) increased 13% to HK$1,448.9 billion with an interim interest of HK$0.50

Shanghai Industrial Environment (00807.HK) 2023 revenue of 7.573 billion yuan, net profit of 604 million yuan

Times Group Holdings (01023.HK) achieved net profit of approximately HK$53.6 million and an interim interest rate of HK2 HK cents in the medium term

Baisheng Group (03368.HK)'s total operating revenue in 2023 increased to 4.18 billion yuan, up 11.4% year-on-year

Jinma Energy (06885.HK) Profit Alert: It is expected that the total overall income attributable to the company's owners will be significantly adjusted to break-even in 2023

Henghe Group (00513.HK)'s interim comprehensive income decreased 25.8% year over year to HK$200 million

Hansi Energy (00554.HK) Profit Warning: Expected annual equity shareholders' share loss of not less than HK$30 million

Jinyuan Hydrogenation (02502.HK) Profit Warning: Profit is expected to be reduced by about half in 2023

China Shengmu (01432.HK) Profit Alert: Net profit due to mother is expected to decrease by about 78% to 82% year-on-year in 2023

Chalk (02469.HK) FY23 Positive Profit Forecast Released: Adjusted Net Profit Expected to Surge 119.3%

Zhongsheng United (03332.HK) Yingxi: Expected annual net profit of about 45 million to 55 million yuan

Dali Group (00029.HK) Yingxi: Expected consolidated net profit attributable to shareholders for the interim period is approximately HK$5.366 billion

[Operational data]

The total value of new contracts signed by Sinopec Refining and Chemical Engineering (02386.HK) in 2023 was 80.252 billion yuan, an increase of 10.7% year-on-year

The electricity sales volume of power plants affiliated with China Resources Electric Power (00836.HK) reached 18.9 million megawatt-hours in January, up 28.9% year-on-year

[Pharmaceutical Innovation]

BeiGene (06160.HK): Tirelizumab received positive opinions from the European Medicines Agency's Human Medicines Committee to support its use in the treatment of patients with non-small cell lung cancer

[Acquisition and sale]

CITIC Resources (01205.HK): Alcoa proposes a non-binding offer to acquire 100% of AWC's issued shares

Zhuohang Holdings (01865.HK) plans to sell 22% of Integral Virtue shares for 6.25 million yuan

Rongzhong Finance (03963.HK): Huiying plans to acquire 49% of Hongtian Venture Capital's shares

[Issuance of additional shares]

Ruili Medical & Aesthetic (02135.HK) proposes a “3 to 1” share offering for the “5 in 1” consolidated shares

[Repurchase Cancellation]

AIA (01299.HK) spent HK$141 million to repurchase 2,215,800 shares on February 26

HSBC Holdings (00005.HK) spent HK$125 million to repurchase 2.1064 million shares on February 23

Haier Smart Home (06690.HK) spent 24.0427 million yuan to buy back 1 million A shares on February 26

Kuaishou-W (01024.HK) spent HK$12.485,700 to buy back 272,600 shares on February 26

Swire Group A (00019.HK) spent HK$10.62 million to repurchase 167,000 shares on February 26

Bank of East Asia (00023.HK) spent HK$5.913 million to repurchase 596,000 shares on February 26

Fangda Holdings (01521.HK) spent HK$2.64 million to buy back 1.464 million shares on February 26

Xiehe New Energy (00182.HK) cancelled 324 million shares on February 26

Bubble Mart (09992.HK) cancelled 5.3 million shares to repurchase shares on February 26

Riel Group (06639.HK) cancelled 1.25 million shares to repurchase shares on February 26

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment